Characterization of the effects of pancreatic polypeptide in the regulation of energy balance.

[1]  P. Mannon.  Pancreatic Polypeptide Family , 2004 .

[2]  A. Smith.  Diagnosis of Prader-Willi syndrome. , 2003, Archives of disease in childhood.

[3]  Rachel L. Batterham,et al.  Gut hormone PYY3-36 physiologically inhibits food intake , 2002, Nature.

[4]  M. Schwartz,et al.  Elevated plasma ghrelin levels in Prader–Willi syndrome , 2002, Nature Medicine.

[5]  A. Inui.  Cancer Anorexia‐Cachexia Syndrome: Current Issues in Research and Management , 2002, CA: a cancer journal for clinicians.

[6]  A. McCullough,et al.  Update on nonalcoholic fatty liver disease. , 2002, Journal of clinical gastroenterology.

[7]  A. Asakawa,et al.  Roles of pancreatic polypeptide in regulation of food intake , 2002, Peptides.

[8]  A. Inui.  Eating behavior in anorexia nervosa—an excess of both orexigenic and anorexigenic signalling? , 2001, Molecular Psychiatry.

[9]  A. McCullough,et al.  Nonalcoholic Fatty Liver Disease , 2001 .

[10]  A. Inui.  Ghrelin: An orexigenic and somatotrophic signal from the stomach , 2001, Nature Reviews Neuroscience.

[11]  G. Marchesini,et al.  Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.

[12]  M. Fujimiya,et al.  Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. , 2001, Gastroenterology.

[13]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[14]  M. Nakazato,et al.  A role for ghrelin in the central regulation of feeding , 2001, Nature.

[15]  G. Chrousos.  The role of stress and the hypothalamic–pituitary–adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes , 2000, International Journal of Obesity.

[16]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[17]  A. Inui,et al.  Transgenic approach to the study of body weight regulation. , 2000, Pharmacological reviews.

[18]  J. Miyazaki,et al.  Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice. , 1999, Gastroenterology.

[19]  M. Fujimiya,et al.  Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice☆ , 1999, Peptides.

[20]  J. Manson,et al.  Annual deaths attributable to obesity in the United States. , 1999, JAMA.

[21]  A. Inui,et al.  Cancer anorexia-cachexia syndrome: are neuropeptides the key? , 1999, Cancer research.

[22]  S. Makino,et al.  The FLS mouse: a new inbred strain with spontaneous fatty liver. , 1999, Laboratory animal science.

[23]  P S Kalra,et al.  Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. , 1999, Endocrine reviews.

[24]  D L Rothman,et al.  Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. , 1999, The Journal of clinical investigation.

[25]  J. Flier,et al.  Obesity and the Hypothalamus: Novel Peptides for New Pathways , 1998, Cell.

[26]  G. Bray,et al.  The MONA LISA hypothesis in the time of leptin. , 1998, Recent progress in hormone research.

[27]  M. Schwartz,et al.  Regulation of body adiposity and the problem of obesity. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[28]  D. McTigue,et al.  Vagal control of digestion: Modulation by central neural and peripheral endocrine factors , 1996, Neuroscience & Biobehavioral Reviews.

[29]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[30]  M. Kasuga,et al.  Effects of pancreatic polypeptide family peptides on feeding and learning behavior in mice. , 1994, The Journal of pharmacology and experimental therapeutics.

[31]  D. McTigue,et al.  Pancreatic polypeptide in dorsal vagal complex stimulates gastric acid secretion and motility in rats. , 1993, The American journal of physiology.

[32]  G. Berntson,et al.  Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome , 1993, Peptides.

[33]  M. Kasuga,et al.  Plasma and cerebroventricular fluid levels of pancreatic polypeptide in the dog: effects of feeding, insulin-induced hypoglycemia, and physical exercise. , 1993, Endocrinology.

[34]  N. Geary,et al.  Glucagon acts in the liver to control spontaneous meal size in rats. , 1993, The American journal of physiology.

[35]  G. Szmukler,et al.  Potential regulators of feeding behavior in anorexia nervosa. , 1992, The American journal of clinical nutrition.

[36]  D. Whitcomb,et al.  Characterization of saturable binding sites for circulating pancreatic polypeptide in rat brain. , 1990, The American journal of physiology.

[37]  B. Rodgers,et al.  Onset of obesity in a 36 year birth cohort study. , 1986, British medical journal.

[38]  D. Booth,et al.  Obesity, overeating, and rapid gastric emptying in rats with ventromedial hypothalamic lesions. , 1986, Science.

[39]  G. A. Tejwani,et al.  Stress induced differential intake of various diets and water by rat: the role of the opiate system. , 1983, Life sciences.

[40]  B. Vialettes,et al.  Low Plasma Levels of Pancreatic Polypeptide in Obesity , 1980, Diabetes.

[41]  I. Correas,et al.  Reduced pancreatic polypeptide secretion in obese subjects. , 1980, The Journal of clinical endocrinology and metabolism.